We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
27 hedge funds and large institutions have $17.4M invested in Interpace Biosciences, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
4% less funds holding
Funds holding: 28 → 27 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
47% less capital invested
Capital invested by funds: $32.9M → $17.4M (-$15.6M)
Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
9
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
RA
Royce & Associates
New York
|
-$601K |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$482K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$54.1K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$32.7K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$7.68K |
